Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2025-12-26 @ 2:54 AM
Study NCT ID:
NCT00996502
Status:
TERMINATED
Last Update Posted:
2019-03-27
First Post:
2009-10-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer
Sponsor:
Columbia University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-14
First Submit QC Date:
None
Study First Post Date:
2009-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-23
Results First Submit QC Date:
None
Results First Post Date:
2016-03-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-26
Last Update Post Date:
2019-03-27
Last Update Post Date Type:
ACTUAL